Previous Close | 1.9900 |
Open | 2.0050 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 1.9490 - 2.0290 |
52 Week Range | 1.8510 - 7.3000 |
Volume | |
Avg. Volume | 20,360 |
Market Cap | 2.664M |
Beta (5Y Monthly) | 0.61 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -10.6400 |
Earnings Date | May 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.00 |
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DALLAS, April 25, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2024 after market close on May 9, 2024.
Arcadia Biosciences (RKDA) reports improved top-line results in the fourth quarter of 2023, which is aided by higher GoodWheat and GLA revenues.